CLEVELAND BIOLABS INC's ticker is CBLI and the CUSIP is 185860202. A total of 18 filers reported holding CLEVELAND BIOLABS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $0 | – | 265 | 0.0% | 0.00% | – |
Q3 2019 | $0 | – | 265 | 0.0% | 0.00% | – |
Q2 2019 | $0 | – | 265 | 0.0% | 0.00% | – |
Q1 2019 | $0 | – | 265 | 0.0% | 0.00% | – |
Q4 2018 | $0 | – | 265 | +1225.0% | 0.00% | – |
Q3 2018 | $0 | – | 20 | 0.0% | 0.00% | – |
Q2 2018 | $0 | – | 20 | 0.0% | 0.00% | – |
Q1 2018 | $0 | – | 20 | 0.0% | 0.00% | – |
Q4 2017 | $0 | -100.0% | 20 | -99.4% | 0.00% | – |
Q3 2017 | $12,000 | -92.5% | 3,570 | -90.8% | 0.00% | -100.0% |
Q2 2017 | $159,000 | +189.1% | 38,680 | 0.0% | 0.00% | +100.0% |
Q1 2017 | $55,000 | -11.3% | 38,680 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $62,000 | -18.4% | 38,680 | -0.4% | 0.00% | 0.0% |
Q3 2016 | $76,000 | -7.3% | 38,843 | +6.0% | 0.00% | 0.0% |
Q2 2016 | $82,000 | -34.9% | 36,643 | -5.7% | 0.00% | -50.0% |
Q1 2016 | $126,000 | -22.7% | 38,843 | -0.1% | 0.00% | -33.3% |
Q4 2015 | $163,000 | +3.2% | 38,888 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $158,000 | +192.6% | 38,888 | +106.4% | 0.00% | +200.0% |
Q2 2015 | $54,000 | -53.4% | 18,843 | -45.1% | 0.00% | -50.0% |
Q1 2015 | $116,000 | – | 34,293 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 400,080 | $2,188,000 | 0.31% |
Sequoia Financial Advisors, LLC | 12,588 | $69,000 | 0.00% |
Cambridge Investment Research Advisors, Inc. | 48,725 | $267,000 | 0.00% |
Archer Investment Corp | 300 | $1,641,000 | 0.00% |
Renaissance Technologies | 98,051 | $536,000 | 0.00% |
VANGUARD GROUP INC | 97,535 | $533,000 | 0.00% |
FMR LLC | 100 | $1,000 | 0.00% |
US BANCORP \DE\ | 1,000 | $5,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 151 | $1,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 51 | $0 | 0.00% |